Pineridge Advisors’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History

Pineridge Advisors’s Portfolio EFTRW Stock Details EFTRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-33	Closed	–	–	683
2024 Q2	$0	Hold	33	–	–	﹤0.01%	684
2024 Q1	$4	Hold	33	–	–	﹤0.01%	608
2023 Q4	$2	Buy	+33	New	+$4	﹤0.01%	810

Pineridge Advisors's EFTRW Position: Q3 2024 in Review

Pineridge Advisors sold out of eFFECTOR Therapeutics, Inc. Warrant (EFTRW) in Q3 2024, closing a stake of 33 shares.

Pineridge Advisors first reported a position in EFTRW in Q4 2023 and held it in 3 quarters. The position peaked at $4 in Q1 2024. 1 fund tracked by Wall St. Rank holds EFTRW as of Q3 2024.

Pineridge Advisors reported no remaining eFFECTOR Therapeutics, Inc. Warrant position as of Q3 2024 after selling out during the quarter.
Pineridge Advisors sold 33 eFFECTOR Therapeutics, Inc. Warrant shares in Q3 2024.
Pineridge Advisors first reported a position in eFFECTOR Therapeutics, Inc. Warrant in Q4 2023 and held it in 3 quarters.
Pineridge Advisors's eFFECTOR Therapeutics, Inc. Warrant position peaked at $4 in Q1 2024.
1 fund tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Warrant as of Q3 2024.

Based on Pineridge Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.